Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Black Diamond Therapeutics Inc (BDTX)

Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Thu Nov 6, 3:01PM CST

CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic...

BDTX : 3.89 (-2.26%)
Black Diamond: Q3 Earnings Snapshot AP - Thu Nov 6, 6:37AM CST

Black Diamond: Q3 Earnings Snapshot

BDTX : 3.89 (-2.26%)
Black Diamond Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire - Thu Nov 6, 6:30AM CST

ORR and preliminary duration of treatment data for the Phase 2 trial of silevertinib in 1L patients with non-classical EGFRm NSCLC on track for this quarter Cash, cash equivalents, and investments...

BDTX : 3.89 (-2.26%)
Black Diamond: Q2 Earnings Snapshot AP - Thu Aug 7, 6:47AM CDT

Black Diamond: Q2 Earnings Snapshot

BDTX : 3.89 (-2.26%)
Black Diamond Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire - Thu Aug 7, 6:30AM CDT

Enrollment completed for the Phase 2 trial of silevertinib (BDTX-1535) in 1L patients with non-classical EGFRm NSCLC (n=43); ORR and preliminary DOR data on track for Q4 2025 Exploring partnership opportunities...

BDTX : 3.89 (-2.26%)
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference GlobeNewswire - Thu May 29, 7:00AM CDT

BDTX : 3.89 (-2.26%)
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update GlobeNewswire - Mon May 12, 3:05PM CDT

BDTX : 3.89 (-2.26%)
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Mon Mar 31, 7:00AM CDT

BDTX : 3.89 (-2.26%)
Black Diamond Therapeutics Shares Jump On New Partnership With France-Based Servier: Retail Sentiment Hits Year-High Stocktwits - Wed Mar 19, 1:28PM CDT

As part of the deal, Servier will develop and commercialize the clinical-stage oncology company’s BDTX-4933, a molecule designed to address solid tumors, including non-small cell lung cancer.

BDTX : 3.89 (-2.26%)
VTI : 330.09 (+0.22%)
IWM : 241.61 (+0.52%)
Servier and Black Diamond Therapeutics Announce Global Licensing Agreement for BDTX-4933, A Targeted Oncology Therapy GlobeNewswire - Wed Mar 19, 6:00AM CDT

BDTX : 3.89 (-2.26%)

Barchart Exclusives

5 Best Dividend Stocks Wall Street Calls Strong Buys Barchart - Fri Nov 7, 6:00PM CST
These dividend stocks demonstrate that stability and growth can coexist in 2025. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot